The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.

by Sha Fu, Ying Liang, Yong-Bin Lin, Fang Wang, Ma-Yan Huang, Zi-Chen Zhang, Jing Wang, Wen-Jian Cen, Jian-Yong Shao
Published 2015-01-01

Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer

by Li‐Yue Sun, Wen‐Jian Cen, Wen‐Ting Tang, Ya‐Kang Long, Xin‐Hua Yang, Xiao‐Meng Ji, Jiao‐Jiao Yang, Ren‐Jing Zhang, Fang Wang, Jian‐Yong Shao, Zi‐Ming Du
Published 2021-10-01

Interfering Expression of Chimeric Transcript SEPT7P2-PSPH Promotes Cell Proliferation in Patients with Nasopharyngeal Carcinoma

by Jing Wang, Guo-Feng Xie, Yuan He, Ling Deng, Ya-Kang Long, Xin-Hua Yang, Jiang-Jun Ma, Rui Gong, Wen-Jian Cen, Zu-Lu Ye, Yi-Xin Zeng, Hai-Yun Wang, Jian-Yong Shao
Published 2019-01-01